Medical Developments International Limited (AU:MVP) has released an update.
Bank of America Corporation has emerged as a substantial holder in Medical Developments International Ltd, with a 5.11% voting power through 5,341,096 ordinary shares as of August 7, 2024. The acquisition includes shares controlled by Merrill Lynch (Australia) Futures Limited and Merrill Lynch Markets (Australia) Pty. Limited, highlighting Bank of America’s strategic positioning in the medical sector.
For further insights into AU:MVP stock, check out TipRanks’ Stock Analysis page.
